Evidence map›Paper›PMID 33603663›Full record

ArticleFrontiers in pharmacology2020

An Integrative Pharmacology-Based Approach for Evaluating the Potential Effects of Purslane Seed in Diabetes Mellitus Treatment Using UHPLC-LTQ-Orbitrap and TCMIP V2.0.

Jinli Hou, Xiang Zhou, Ping Wang, Chunhui Zhao, Yuewen Qin, Feng Liu, Liping Yu, Haiyu Xu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Frontiers in nutrition · 2026
    Article
  3. Article
  4. Identification ofInternational journal of molecular sciences · 2023
    Article
  5. Article
  6. Article
  7. Effects ofIranian journal of basic medical sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Jinli HouInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
Xiang ZhouState Key Laboratory of Innovative Drug and Efficient Energy-Saving Pharmaceutical Equipment, Jiangxi University of Traditional Chinese Medicine, Nanchang, China.
Ping WangInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
Chunhui ZhaoInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
Yuewen QinInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
Feng LiuMedical College, Shaanxi Institute of International Trade and Commerce, Xianyang, China.
Liping YuGuangzhou Zhongda Pharmaceutical Development Co. Ltd., Guangzhou, China.
Haiyu XuInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNJiangxi University of Traditional Chinese Medicine · CNShaanxi Institute of International Trade & Commerce · CNYunnan University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

diabetes mellitusmolecular networkpurslane seedTCMIP v20UHPLC-LTQ-orbitrap

Identifiers

PMID33603663
PMCPMC7884824
OpenAlexW3128530944

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.